| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |